Atleast 50% more geographically distributed Govt sites be included: CDSCO panel Tells IQVIA in Milvexian study Dr. Divya Colin3 April 2024 6:00 PM ISTNew Delhi: Reviewing the proposal presented by IQVIA regarding the waiving of the specific condition in the Milvexian study, the Subject Expert...
Oral Factor XIa Inhibitor Milvexian Fails to Demonstrate Impressive Results for Preventing Stroke Aditi4 Jan 2024 10:30 PM ISTPeople with factor XI deficiency have lower rates of ischemic stroke and infrequent spontaneous bleeding, presenting an essential role in...
Janssen Milvexian gets USFDA fast track designation for Ischemic Stroke, Acute Coronary Syndrome, Atrial Fibrillation Ruchika Sharma26 May 2023 3:15 PM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced that all three prospective indications for milvexian, an ...
Bristol Myers Squibb, Janssen launch Phase 3 Librexia clinical trial program evaluating Milvexian Ruchika Sharma5 March 2023 2:30 PM ISTPrinceton: Bristol Myers Squibb in collaboration with Janssen Pharmaceuticals, Inc., one of the Janssen Pharmaceutical Companies of Johnson...
Milvexian shows potential to reduce risk of ischaemic stroke Dr. Kamal Kant Kohli9 Sept 2022 7:15 PM ISTA phase 2 trial in patients with a prior ischaemic stroke or high-risk transient ischaemic attack (TIA) has indicated that milvexian should be further...
